Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Lytix Biopharma AS. (8/21/17). "Press Release: Lytix Strengthens the Board with Clinical Development and Commercial Oncology Experience".
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.
Edwin Klumper was elected as a new member to the board of Lytix on 27 June. He is a life science entrepreneur and combines a scientific and business background. He holds an MBA from RSM.
RSM uses cookies to measure website statistics, enable social media sharing and for marketing purposes.
By clicking accept cookies or by continuing to use this website, you are giving consent for us to set cookies when visiting this website.
See our cookie policy for more information about cookies and how to adjust your cookie settings.